Product Recalls: January 17, 2019 – February 13, 2019

Health Letter, March 2019

CLASS II

Amlodipine and valsartan tablets; 5 mg/160 mg, 10 mg/160 mg, 5 mg/320 mg or 10 mg/320 mg; 30-count bottles. Manufactured for: Aurobindo Pharma USA, Inc.

Esterified estrogens and methyltestosterone tablets, 0.625 mg/1.25 mg or 1.25 mg/2.5 mg, 100-count bottle. Manufactured By: Syntho Pharmaceuticals, Inc.

Ezetimibe and simvastatin tablets, 10 mg/80 mg, 1,000-count bottles. Manufactured by: Teva Pharmaceuticals Ind. Ltd.

Fexofenadine HCl tablets, 180 mg, 30- or 500-count bottles. Manufactured by: Mylan Pharmaceuticals Inc.

Irbesartan tablets, 300 mg, 90 count. Manufactured by: Zhejiang Huahai Pharmaceutical Co.

Irbesartan and hydrochlorothiazide tablets, 150 mg/12.5 mg or 300 mg/12.5 mg, 30 or 90 count. Manufactured by: Zhejiang Huahai Pharmaceutical Co.

Olmesartan medoxomil and hydrochlorothiazide tablets, 40 mg/25 mg, 30- or 90-count bottle. Manufactured by: Teva Pharmaceutical, IND. LTD.

Valsartan tablets, 320 mg, 90-count bottles. Manufactured for: Aurobindo Pharma USA, Inc.

Valsartan and hydrochlorothiazide tablets; 320mg/12.5 mg, 160mg/12.5 mg, 320 mg/25 mg, 80 mg/12.5 mg or 160 mg/25 mg; 90-count bottle. Manufactured for: Aurobindo Pharma USA, Inc.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

CONSUMER PRODUCTS

For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.